Vertex Pharmaceuticals Incorporated company logo
Vertex Pharmaceuticals Incorporated logo

VRTX EBITDA

Annual EBITDA

$486.30M$4.12B-89.44%

Summary

Current Value
As of today, VRTX annual EBITDA is $486.30M, down -89.44% on
Historical Performance
VRTX annual EBITDA is down -83.33% over the past 3 years, and down -68.83% over the past 5 years
All-Time High Comparison
VRTX annual EBITDA is currently -89.44% below its historical high of $4.61B set on
3-Year Low Comparison
VRTX annual EBITDA is at its 3-year low
Sector Comparison
VRTX annual EBITDA is higher than 91.34% of companies in Healthcare sector

EBITDA Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

VRTX Performance
MetricDateValue1Y3Y5Y15Y
Annual EBITDA$486.30M-89.4%-83.3%-68.8%+181.2%
Quarterly EBITDA$1.33B+13.6%+21.6%+88.1%+793.8%
TTM EBITDA$4.73B+5466.1%+15.4%+70.8%+847.3%
Price$460.59+11.4%+53.0%+102.8%+1094.8%
PE Ratio32.46+38.3%+47.1%
Annual Revenue$10.98B+11.6%+44.5%+165.9%+10000.0%
Annual EPS-$2.08-115.0%-123.0%-146.0%+44.0%
Annual EBIT$279.10M-93.7%-90.0%-80.8%+144.4%
Annual Net Income-$535.60M-114.8%-122.9%-145.5%+16.6%

EBITDA Highs

VRTX Annual EBITDA Highs Comparison
PeriodHighDateCurrent
3Y$4.61B-89.4%
5Y$4.61B-89.4%
All$4.61B-89.4%

EBITDA Lows

VRTX Annual EBITDA Lows Comparison
PeriodLowDateCurrent
3Y$486.30Mat low
5Y$486.30Mat low
All-$704.89M+169.0%

EBITDA History

YearValueChange
$486.30M-89.4%
$4.61B+3.8%
$4.44B+52.0%
$2.92B-11.2%
$3.28B+110.5%
$1.56B+109.4%
$745.13M+547.9%
$115.01M+52.4%
$75.46M+118.3%
-$411.25M+31.3%
-$598.76M-7.9%
-$554.75M-750.9%
$85.23M-36.0%
$133.17M+118.9%
-$704.89M-17.7%
-$598.88M-40.5%
-$426.19M-10.6%
-$385.21M-93.1%
YearValueChange
-$199.52M-74.3%
-$114.45M-6.4%
-$107.59M+27.9%
-$149.27M-21.3%
-$123.05M-26.7%
-$97.14M-294.0%
-$24.65M+44.4%
-$44.30M-2.5%
-$43.20M-176.9%
-$15.60M+57.0%
-$36.30M-59.2%
-$22.80M-32.6%
-$17.20M-437.3%
$5.10M+170.8%
-$7.20M-89.5%
-$3.80M+7.3%
-$4.10M-

FAQ

  • What is the current annual EBITDA of VRTX?

    As of today, VRTX annual EBITDA is $486.30M

  • What is 1-year change in VRTX annual EBITDA?

    VRTX annual EBITDA is down -89.44% year-over-year

  • What is 3-year change in VRTX annual EBITDA?

    VRTX annual EBITDA is down -83.33% over the past 3 years

  • How far is VRTX annual EBITDA from its all-time high?

    VRTX annual EBITDA is currently -89.44% below its historical high of $4.61B set on December 31, 2023

  • How does VRTX annual EBITDA rank versus sector peers?

    VRTX annual EBITDA is higher than 91.34% of companies in Healthcare sector

  • When is VRTX next annual earnings release?

    The next annual earnings release for VRTX is on

EBITDA Formula

Data Sources & References

  1. VRTX Official Website www.vrtx.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/875320/000087532025000232/0000875320-25-000232-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/875320/000087532025000053/0000875320-25-000053-index.htm
  4. VRTX Profile on Yahoo Finance finance.yahoo.com/quote/VRTX
  5. VRTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vrtx